This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yonemochi, H. Articles by Ito, M. Search for Related Content PubMed PubMed Citation Articles by Yonemochi, H. Articles by Ito, M.

(Circulation. 1998;97:2268-2273.)
© 1998 American Heart Association, Inc.

Basic Science Reports

Mechanism of ß-Adrenergic Receptor Upregulation Induced by ACE Inhibition in Cultured Neonatal Rat Cardiac Myocytes

Roles of Bradykinin and Protein Kinase C

Hidetoshi Yonemochi, MD; Seikoh Yasunaga, MD; Yasusi Teshima, MD; Tetsu Iwao, MD; Kumiko Akiyoshi, MD; Mikiko Nakagawa, MD; Tetsunori Saikawa, MD; ; Morio Ito, MD

From the Department of Laboratory Medicine (H.Y., T.I., M.N., M.I.) and the First Department of Internal Medicine (S.Y., Y.T., K.A., T.S.), Oita (Japan) Medical University.

Correspondence to Hidetoshi Yonemochi, MD, Department of Laboratory Medicine, Oita Medical University, Idaigaoka 1–1, Hasama-machi, Oita 879–55, Japan. E-mail yonemo{at}pios.oita-med.ac.jp

Background—Although bradykinin is thought to contribute to the effects of ACE inhibitors on the cardiovascular system, its precise role remains to be elucidated. Evidence suggests that bradykinin might be important in the upregulation of ß-adrenergic receptors (ß-ARs) induced by ACE inhibitors, and the role of bradykinin in this effect has now been investigated with cultured neonatal rat cardiac myocytes.

Methods and Results—The density of ß-ARs on the myocyte surface was determined with a binding assay with [³H]CGP-12177. Incubation of cultured myocytes for 24 hours with the ACE inhibitor captopril (1 µmol/L) increased ß-AR density by 35% and enhanced the response of cells to isoproterenol but not to forskolin. Neither an angiotensin-II type 1 (AT₁) receptor antagonist, CV-11974, nor angiotensin-I affected ß-AR density. However, the bradykinin B₂ receptor antagonist Hoe 140 abolished the effect of captopril on ß-AR upregulation in a dose-dependent manner. The protein kinase C inhibitor staurosporine (20 nmol/L) but neither indomethacin nor L-NAME also inhibited captopril-induced upregulation of ß-ARs. Exogenous bradykinin increased the spontaneous beating frequency of cultured myocytes and Hoe 140 abolished this effect. Bradykinin level in the medium increased 1.4-fold by the treatment of cultured myocytes with captopril for 24 hours.

Conclusions—The results suggest that captopril enhances ß-AR responsiveness by inducing ß-AR upregulation and that the latter effect is mediated by activation of bradykinin B₂ receptors and protein kinase C. These observations also offer insight into the different roles of ACE inhibitors and AT₁ receptor antagonists in the treatment of heart failure.

Key Words: bradykinin • receptors, adrenergic, beta • angiotensin • myocytes

This article has been cited by other articles:

				K. Chakir, S. K. Daya, T. Aiba, R. S. Tunin, V. L. Dimaano, T. P. Abraham, K. Jaques, E. W. Lai, K. Pacak, W.-Z. Zhu, et al. Mechanisms of Enhanced {beta}-Adrenergic Reserve From Cardiac Resynchronization Therapy Circulation, March 10, 2009; 119(9): 1231 - 1240. [Abstract] [Full Text] [PDF]

				G. E. Haddad, B. R. Coleman, A. Zhao, and K. N. Blackwell Regulation of atrial contraction by PKA and PKC during development and regression of eccentric cardiac hypertrophy Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H695 - H704. [Abstract] [Full Text] [PDF]

				M. Henriksson, E. Stenman, and L. Edvinsson Intracellular Pathways Involved in Upregulation of Vascular Endothelin Type B Receptors in Cerebral Arteries of the Rat Stroke, June 1, 2003; 34(6): 1479 - 1483. [Abstract] [Full Text] [PDF]

				M. Zaugg, M. C. Schaub, T. Pasch, and D. R. Spahn Modulation of {beta}-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action Br. J. Anaesth., January 1, 2002; 88(1): 101 - 123. [Abstract] [Full Text] [PDF]

				M. M. Multani, R. S. Krombach, A. T. Goldberg, M. K. King, J. W. Hendrick, J. A. Sample, S. C. Baicu, C. Joffs, M. deGasparo, and F. G. Spinale Myocardial Bradykinin Following Acute Angiotensin-Converting Enzyme Inhibition, AT1 Receptor Blockade, or Combined Inhibition in Congestive Heart Failure Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2001; 6(4): 369 - 376. [Abstract] [PDF]

				T. Suzuki and T. Miyauchi A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1399 - R1406. [Abstract] [Full Text] [PDF]

				H. Yonemochi, S. Yasunaga, Y. Teshima, N. Takahashi, M. Nakagawa, M. Ito, and T. Saikawa Rapid Electrical Stimulation of Contraction Reduces the Density of {beta}-Adrenergic Receptors and Responsiveness of Cultured Neonatal Rat Cardiomyocytes : Possible Involvement of Microtubule Disassembly Secondary to Mechanical Stress Circulation, June 6, 2000; 101(22): 2625 - 2630. [Abstract] [Full Text] [PDF]

				R. S. Krombach, J. H. McElmuray, D. M. Gay, M. J. Clair, R. Mukherjee, A. T. Goldberg, S. C. Baicu, and F. G. Spinale Bradykinin Degradation and Relation to Myocyte Contractility Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 291 - 299. [Abstract] [PDF]

				A.H.J. Danser, J. J Saris, M. P Schuijt, and J. P van Kats Is there a local renin--angiotensin system in the heart? Cardiovasc Res, November 1, 1999; 44(2): 252 - 265. [Abstract] [Full Text] [PDF]

				C. M. Kramer, P. D. Nicol, W. J. Rogers, P. S. Seibel, C. S. Park, and N. Reichek beta -Blockade improves adjacent regional sympathetic innervation during postinfarction remodeling Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1429 - H1434. [Abstract] [Full Text] [PDF]